Skip to main content
. Author manuscript; available in PMC: 2015 Oct 28.
Published in final edited form as: Am J Perinatol. 2014 Oct 5;32(7):645–652. doi: 10.1055/s-0034-1390348

Table 1.

Subject clinical characteristics (infants included in final analyses; n=20)

Infants without severe* IVH (n=20) Infants with IVH (n=2)

Estimated gestational age at birth (weeks, mean ± sd) 26.5 ± 1.7 24 (n/a) 26 (n/a)

Median post-natal age at the time of study (days) 2 [1-3] 2 2

Gender
    Male 6
    Female 14

Race
    African American 16
    Caucasian 4

Birthweight (grams, mean ± sd) 930 ± 220

CRIB scores (mean ± sd) 3.6 ± 3.1 5 6

Respiratory support at the time of study
    None 1
    Biphasic/NCPAP 12
    SIMV 7

Inotropic support at the time of study 0

PDA (*none treated during study monitoring)
- Not clinically significant/never treated 12
- Treated with indomethacin alone 5
- Surgical ligation 3

Proven sepsis in the first 7 days of life 0 0

Intraventricular hemorrhage
    None 19
    Grade I 1
    Grade IV 0

(CRIB = clinical risk index for babies, NCPAP = nasal continuous positive airway pressure, SIMV = synchronized intermittent mandatory ventilation, PDA = patent ductus arteriosus)

*

severe IVH is defined as grade III and/or grade IV IVH on either sides of the brain based on routine clinical ultrasounds within the first 7 days of life.